BridgeBio secures $1 billion in equity financing ahead of three upcoming drug launches
read at Endpoints ↗DealNeutral
BridgeBio Pharma announced it has raised about $1 billion through a preferred equity transaction.
The new capital will strengthen its balance sheet as the company prepares three potential drug launches slated for the next year.
The financing highlights investor confidence in BridgeBio’s pipeline, though specific drug details were not disclosed.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “BridgeBio adds $1B as it prepares three more drug launches”
read at Endpoints ↗81 words · retrieved Jul 1
comments(0)
5-min edit window · permanent after that